norcantharidin has been researched along with Peritoneal Carcinomatosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, S; Liu, Y; Ma, W; Wang, B; Wang, Y; Wen, Q; Wu, Z; Xiao, S; Xiong, K; Zhou, P | 1 |
1 other study(ies) available for norcantharidin and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Intraperitoneal administration of thermosensitive hydrogel Co-loaded with norcantharidin nanoparticles and oxaliplatin inhibits malignant ascites of hepatocellular carcinoma.
Topics: Animals; Ascites; Bridged Bicyclo Compounds, Heterocyclic; Carcinoma, Hepatocellular; Cell Line, Tumor; Hydrogels; Liver Neoplasms; Mice; Nanoparticles; Oxaliplatin; Peritoneal Neoplasms | 2022 |